# IPG Photonics Corp: Form 10-Q for the period ended Mar 31, 2019

- Company: [IPG Photonics Corp](/companies/ipgp.md) (CIK 1111928)
- Form: 10-Q
- Filed: 2019-05-08
- Accepted by EDGAR: May 8, 2019, 16:08 ET
- Period: 2019-03-31
- Accession: 0001111928-19-000079
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1111928/000111192819000079/ipgp-20190331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1111928/000111192819000079/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-01-01 to 2019-03-31 | $315.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-01-01 to 2019-03-31 | $166.1m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2019-01-01 to 2019-03-31 | $148.9m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-01-01 to 2019-03-31 | $32.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2019-01-01 to 2019-03-31 | $68.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2019-01-01 to 2019-03-31 | $17.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-01-01 to 2019-03-31 | $55.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-01-01 to 2019-03-31 | $1.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-01-01 to 2019-03-31 | $1.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-01-01 to 2019-03-31 | 53,874,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2019-01-01 to 2019-03-31 | $43.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2019-01-01 to 2019-03-31 | $33.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2019-01-01 to 2019-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-03-31 | $548.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-03-31 | $1.79bn | us-gaap:AssetsCurrent |
| Total assets | at 2019-03-31 | $2.63bn | us-gaap:Assets |
| Current liabilities | at 2019-03-31 | $209.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-03-31 | $360.4m | us-gaap:Liabilities |
| Long-term debt | at 2019-03-31 | $40.8m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-03-31 | $3.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2019-03-31 | $2.27bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 35,106 characters.

*You should read the following discussion in conjunction with our consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward looking statements that are based on management's current expectations, estimates and projections about our business and operations. Our actual results may differ materially from those currently anticipated and expressed in such forward-looking statements. See "Cautionary Statement Regarding Forward-Looking Statements."*

### Overview

We develop and manufacture a broad line of high-performance fiber lasers, fiber amplifiers and diode lasers that are used in numerous applications, primarily in materials processing. In addition, we offer laser-based systems for certain markets and applications. We sell our products globally to original equipment manufacturers ("OEMs"), system integrators and end users. We market our products internationally primarily through our direct sales force.

We are vertically integrated such that we design and manufacture most of the key components used in our finished products, from semiconductor diodes to optical fiber preforms, finished fiber lasers and amplifiers. We also manufacture certain complementary products used with our lasers, including optical delivery cables, fiber couplers, beam switches, optical processing heads and chillers.

### Factors and Trends That Affect Our Operations and Financial Results

In reading our financial statements, you should be aware of the following factors and trends that our management believes are important in understanding our financial performance.

*Net sales.* We derive net sales primarily from the sale of fiber lasers and amplifiers. We also sell diode lasers, communications systems, laser systems and complementary products. We sell our products through our direct sales organization and our network of distributors and sales representatives, as well as system integrators. We sell our products to OEMs that supply materials processing laser systems, communications systems, medical laser systems and other laser systems for advanced applications to end users. We also sell our products to end users that build their own systems, which incorporate our products or use our products as an energy or light source. Our scientists and engineers work closely with OEMs, systems integrators and end users to analyze their system requirements and match appropriate fiber laser or amplifier specifications. Our sales cycle varies substantially, ranging from a period of a few weeks to as long as one year or more, but is typically several months.

Sales of our products are, in general, recognized upon shipment, provided that no obligations remain and collection of the receivable is reasonably assured. Our sales typically are made on a purchase order basis rather than through long-term purchase commitments. Revenue from sales of customized robotic systems is recognized over time.

We develop our products to standard specifications and use a common set of components within our product architectures. Our major products are based upon a common technology platform. We continually enhance these and other products by improving their components and developing new components and new product designs.

The average selling prices of our products generally decrease as the products mature. These decreases result from factors such as decreased manufacturing costs and increases in unit volumes, increased competition, the introduction of new products and market share considerations. In the past, we have lowered our selling prices in order to penetrate new markets and applications. Furthermore, we negotiate discounted selling prices from time to time with certain customers that place high unit volume orders.

*Gross margin*. Our total gross margin in any period can be significantly affected by total net sales in any period, by product mix, by sales mix between OEM customers who purchase devices from us in high unit volumes and other customers, by mix of sales in different geographies, by competitive factors and by other factors such as changes in foreign exchange rates relative to the U.S. Dollar, some of which are not under our control.

Historically, we have been able to offset decreasing average selling prices with reductions in the cost of our components, subassemblies and finished products. However, recent average selling price pressure has been more pronounced, and as a result, we have only been able to partially offset the impact of the decrease in selling prices; it will take further cost reductions, which may not be achieved, in order for laser gross margins to increase.

Our gross margin can be significantly affected by product mix. Within each of our product categories, the gross margin is generally higher for devices with greater average power. These higher power products often have better performance, more difficult specifications to attain and fewer competing products in the marketplace. Higher power lasers also use a greater number of optical components, improving absorption of fixed overhead costs and enabling economies of scale in manufacturing. The gross margin for certain specialty products may be higher because there are fewer or sometimes no equivalent competing products. Customers that purchase devices in greater unit volumes generally receive lower prices per device than customers that purchase fewer units. These lower selling prices to high unit volume customers may be partially offset by the improved absorption of fixed overhead costs associated with larger product volumes, which drive economies of scale in manufacturing. Finally, gross margin on systems and communication components can be lower than margins for our laser and amplifier sources, depending on the configuration, volume and competitive forces, among other factors.

The mix of sales between OEM customers and other customers can affect gross margin because we provide sales price discounts on products based on the number of units ordered. As the number of OEM customers increase and the number of units ordered increases, the average sales price per unit will be reduced. We expect that the impact of reduced sales price per unit will be offset by the manufacturing efficiency provided by high unit volume orders, but the timing and extent of achieving these efficiencies may not always match the mix of sales in any given time period or be realized at all.

Fluctuations in foreign exchange rates can affect gross margin. Generally, when the U.S. Dollar weakens as compared to the Euro, Chinese Yuan or other foreign currencies in which our product is sold, it will benefit gross margin. When the U.S. dollar strengthens as compared to foreign currencies in which our product is sold, it will be a detriment to gross margin.

We also regularly review our inventory for items that are slow-moving, have been rendered obsolete or determined to be excess. Any provision for such slow-moving, obsolete or excess inventory affects our gross margins. For example, we recorded provisions for slow-moving, obsolete or excess inventory totaling $4.8 million and $3.4 million for the three months ended March 31, 2019 and 2018, respectively, and $13.0 million, $16.9 million and $22.80 million for the years ended December 31, 2018, 2017 and 2016, respectively.

*Sales and marketing expense.* We expect to continue to expand our worldwide direct sales organization, build and expand applications centers, hire additional sales and marketing personnel at our existing and new geographic locations as well as to support sales of new product lines, increase the number of units for demonstration purposes and otherwise increase expenditures on sales and marketing activities in order to support the growth in our net sales. As such, we expect that our sales and marketing expenses will increase in the aggregate.

*Research and development expense.* We plan to continue to invest in research and development to improve our existing components and products and develop new components, products, systems and applications technology. The amount of research and development expense we incur may vary from period to period. In general, if net sales continue to increase we expect research and development expense to increase in the aggregate.

*Long-lived assets impairments*. We review our intangible assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Goodwill is required to be tested for impairment at least annually. Negative industry or economic trends, including reduced estimates of future cash flows, disruptions to our business, slower growth rates, lack of growth in our relevant business units or differences in the estimated product acceptance rates could lead to impairment charges against our long-lived assets, including goodwill and other intangible assets.

Our valuation methodology for assessing impairment requires management to make significant judgments and assumptions based on historical experience and to rely heavily on projections of future operating performance at many points during the analysis. Also, the process of evaluating the potential impairment of goodwill is subjective. We operate in a highly competitive environment and projections of future operating results and cash flows may vary significantly from actual results. Additionally, if our analysis indicates potential impairment to goodwill in one or more of our reporting units, we may be required to record additional charges to earnings in our financial statements, which could negatively affect our results of operations.

*General and administrative expense.* We expect our general and administrative expenses to increase as we continue to invest in systems and resources in management, finance, legal, information technology, human resources and administration to support our worldwide operations and our acquisition strategy. Legal expenses vary from quarter to quarter based primarily upon the level of transaction activities and litigation.

*Foreign exchange.* Because we are a U.S. based company doing business globally, we have both translational and transactional exposure to fluctuations in foreign currency exchange rates. Changes in the relative exchange rate between the U.S. dollar and the foreign currencies in which our subsidiaries operate directly affects our sales, costs and earnings. Differences in the relative exchange rates between where we sell our products and where we incur manufacturing and other operating costs (primarily in the U.S., Germany and Russia) also affects our costs and earnings. Certain currencies experiencing significant exchange rate fluctuations like the Euro, the Russian Ruble, the Japanese Yen and Chinese Yuan have had and could have an additional significant impact on our sales, costs and earnings. Our ability to adjust the foreign currency selling prices of products in response to changes in exchange rates is limited and may not offset the impact of the changes in exchange rates on the translated value of sales or costs. In addition, if we increase the selling price of our products in local currencies, this could have a negative impact on the demand for our products.

*Major customers.* While we have historically depended on a few customers for a large percentage of our annual net sales, the composition of this group can change from year to year. Net sales derived from our five largest customers as a percentage of our net sales was 23% for the three months ended March 31, 2019 and 26%, 28% and 22% for the full years 2018, 2017 and 2016, respectively. One of our customers accounted for 9% and 11% of our net sales for the three months ended March 31, 2019 and 2018. We seek to add new customers and to expand our relationships with existing customers. We anticipate that the composition of our significant customers will continue to change. If any of our significant customers substantially reduced their purchases from us, our results would be adversely affected.

### Results of Operations for the three months ended March 31, 2019 compared to the three months ended March 31, 2018

*Net sales.* Net sales decreased by $44.8 million, or 12.5%, to $315.0 million for the three months ended March 31, 2019 from $359.9 million for the three months ended March 31, 2018.

| Sales by Application | Three Months Ended March 31, 2019 | % of Total | 2018 | % of Total | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Materials processing | $301,085 | 95.6% | $339,214 | 94.3% | $(38,129) | (11.2)% |
| Other applications | 13,962 | 4.4% | 20,650 | 5.7% | (6,688) | (32.4)% |
| Total | $315,047 | 100.0% | $359,864 | 100.0% | $(44,817) | (12.5)% |

| Sales by Product |  |  |  |  |  |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| High Power Continuous Wave ("CW") Lasers | $179,019 | 56.8% | $230,574 | 64.1% | $(51,555) | (22.4)% |
| Medium and Low Power CW Lasers | 15,598 | 5.0% | 25,399 | 7.1% | (9,801) | (38.6)% |
| Pulsed Lasers | 31,437 | 10.0% | 38,253 | 10.6% | (6,816) | (17.8)% |
| Quasi-Continuous Wave ("QCW") Lasers | 14,166 | 4.5% | 16,200 | 4.5% | (2,034) | (12.6)% |
| Laser and Non-Laser Systems | 32,631 | 10.4% | 9,471 | 2.6% | 23,160 | 244.5% |
| Other Revenue including Amplifiers, Service, Parts, Accessories and Change in Deferred Revenue | 42,196 | 13.3% | 39,967 | 11.1% | 2,229 | 5.6% |
| Total | $315,047 | 100.0% | $359,864 | 100.0% | $(44,817) | (12.5)% |

### Materials processing

Sales for materials processing applications decreased due to lower sales from high power lasers, medium power lasers, pulsed lasers and QCW lasers offset by increased revenue from laser and non-laser systems.

- The decline in high power lasers related to the decrease in sales of cutting and laser sintering applications which were partially offset by strength in welding applications. Within cutting applications, decreased sales were driven by lower average selling prices and weaker demand in China and Europe. The increase in sales of high power lasers used in metal welding applications was driven by increased sales into the general manufacturing industry and electric vehicle battery welding, which was partially offset by decreased sales of welding applications into the traditional automotive industry as well as a decrease in average selling prices.
- The decrease in medium and low power sales related to weakness in fine cutting applications and laser sintering for metal-based additive manufacturing. The reduced revenue in fine cutting applications was due in part to the ongoing transition to kilowatt scale high power lasers for these applications.
- The decrease in pulsed laser sales was due to the decline in sales of low and high power pulsed products, which were partially offset by the growth in green and ultrafast pulsed lasers.
- QCW laser sales decreased due to lower demand for fine processing and consumer electronics applications.
- The increase in laser and non-laser systems sales was largely due to the acquisition of Genesis and partially driven by growth in macro-systems for welding, drilling, and ablation applications.
- The increase in Other Revenue within the Sales by Product chart above was driven by growth in accessories and service sales.

Sales from other applications decreased due to a sales decline in communications, government, medical, semiconductor and scientific applications, partially offset by an increase in the instrument market from ramping sales of laser-based digital cinema projection systems. Government sales decreased largely due to the decrease in sales of directed energy applications in the quarter.

*Cost of sales and gross margin.* Cost of sales increased by $9.6 million, or 6.2%, to $166.1 million for the three months ended March 31, 2019 from $156.5 million for the three months ended March 31, 2018. Our gross margin decreased to 47.3% for the three months ended March 31, 2019 from 56.5% for the three months ended March 31, 2018. Gross margin decreased mainly due to lower revenues in the first quarter of 2019 versus the year ago period which resulted in lower absorption of manufacturing expenses. In addition, gross margin was impacted by a decrease in average selling prices and higher inventory provisions as compared to the first quarter of 2018. Product mix also reduced gross margins because the systems sold by Genesis, a business that we acquired in December 2018, have a lower gross margin than the core laser business.

*Sales and marketing expense.* Sales and marketing expense increased by $5.8 million, or 42.6%, to $19.3 million for the three months ended March 31, 2019 compared with $13.5 million for the three months ended March 31, 2018. This change was primarily a result of increases in personnel, commissions, and depreciation expense. The acquisition of Genesis increased sales and marketing expense by $3.3 million. As a percentage of sales, sales and marketing expense increased to 6.1% of sales for the three months ended March 31, 2019 from 3.8% for the three months ended March 31, 2018.

*Research and development expense.* Research and development expense increased by $4.0 million, or 13.8%, to $32.5 million for the three months ended March 31, 2019, compared to $28.5 million for the three months ended March 31, 2018. This change was primarily a result of increases in personnel and R&D materials, partially offset by reductions in contractors expense. Research and development continues to focus on developing new products, enhancing performance of existing components, improving production processes and developing manufacturing of new components such as crystals and refining production processes to improve manufacturing yields and productivity. New products include lasers that operate at different wavelengths such as UV, visible and mid-IR, lasers with ultrafast pulses, laser based systems for material processing, projection, display and medical as well as accessories such as welding and cutting heads. In addition to new products research and development is focused on enhancing the performance of our existing products by improving their electrical efficiency and increasing their average power. As a percentage of sales, research and development expense increased to 10.3% for the three months ended March 31, 2019 from 7.9% for the three months ended March 31, 2018.

*General and administrative expense.* General and administrative expense increased by $1.7 million, or 6.7%, to $27.2 million for the three months ended March 31, 2019 from $25.5 million for the three months ended March 31, 2018. This change was primarily a result of the acquisition of Genesis and increases in bad debt expense. As a percentage of sales, general and administrative expense increased to 8.6% for the three months ended March 31, 2019 from 7.1% for the three months ended March 31, 2018.

*Effect of exchange rates on net sales, gross profit and operating expenses.* We estimate that, if exchange rates relative to the U.S. Dollar had been the same as one year ago, which were on average Euro 0.81, Russian Ruble 57, Japanese Yen 108 and Chinese Yuan 6.36, respectively, we would have expected net sales to be $14.7 million higher, gross profit to be $7.8 million higher and total operating expenses to be $2.6 million higher.

*Loss (gain) on foreign exchange.* We incurred a foreign exchange loss of $1.6 million for the three months ended March 31, 2019 as compared to a $5.3 million gain for the three months ended March 31, 2018. The foreign exchange loss for the three months ended March 31, 2019 was primarily attributable to appreciation of the Russian Ruble offset by gains attributable to the appreciation of the Chinese Yuan and depreciation of the Euro. The foreign exchange gain for the three months ended March 31, 2018 was primarily attributable to the appreciation of the Chinese Yuan as compared to the U.S. Dollar.

*Provision for income taxes.* Provision for income taxes was $17.3 million (effective tax rate of 24.0%) for the three months ended March 31, 2019 compared to $35.5 million (effective tax rate of 25.0%) for the three months ended March 31, 2018. There were net discrete tax benefits included in tax expense of $2.3 million and $6.5 million for the three months ended March 31, 2019 and 2018, respectively.

*Net income attributable to IPG Photonics Corporation.* Net income attributable to IPG Photonics Corporation decreased by $51.1 million to $55.2 million for the three months ended March 31, 2019 compared to $106.3 million for the three months ended March 31, 2018. Net income attributable to IPG Photonics Corporation as a percentage of our net sales decreased by 12.0 percentage points to 17.5% for the three months ended March 31, 2019 from 29.5% for the three months ended March 31, 2018 due to the factors described above.

### Liquidity and Capital Resources

Our principal sources of liquidity as of March 31, 2019 consisted of cash and cash equivalents of $548.9 million, short-term investments of $481.1 million, unused credit lines and overdraft facilities of $105.8 million and other working capital (excluding cash and cash equivalents and short-term investments) of $552.2 million. This compares to cash and cash equivalents of $544.4 million, short-term investments of $500.4 million, unused credit lines and overdraft facilities of $107.4 million and other working capital (excluding cash and cash equivalents and short-term investments) of $514.9 million as of December 31, 2018. The increase in cash and cash equivalents of $4.6 million relates primarily to cash provided by operating activities of $43.7 million, offset by cash used in investing activities of $23.2 million and cash used in financing activities of $7.0 million. In addition, the effect of exchange rates decreased cash and cash equivalents by $6.0 million.

Short-term investments at March 31, 2019, consist of liquid investments including U.S. government and government agency notes, corporate notes, non-U.S. government notes, commercial paper and certificates of deposit with original maturities of greater than three months but less than one year. We also hold long-term investments, included in other assets on the consolidated balance sheets, which consist of auction rate securities totaling $0.9 million.

Our long-term debt consists of two long-term notes with a combined total outstanding balance at March 31, 2019 of $44.5 million of which $3.7 million is the current portion. We have an unsecured long-term note with an outstanding principal balance at March 31, 2019 of $20.5 million, of which $1.2 million is the current portion. The interest on this unsecured long-term note is variable at 1.2% above LIBOR and is fixed using an interest rate swap at 2.9% per annum. The unsecured long-term note matures in May 2023, at which time the outstanding principal balance will be $15.4 million. We have another long-term note that is secured by our corporate aircraft with an outstanding principal balance of $24.0 million, of which $2.5 million is the current portion. The interest on this collateralized long-term note is fixed at 2.7% per annum. The collateralized long-term note matures in July 2022, at which time the outstanding principal balance will be $15.4 million.

We believe that our existing cash and cash equivalents, short-term investments, our cash flows from operations and our existing lines of credit provide us with the financial flexibility to meet our liquidity and capital needs, as well as to complete certain acquisitions of businesses and technologies. We intend to continue to pursue acquisition opportunities based upon market conditions and the strategic importance and valuation of the target company. We may consider issuing debt or equity to finance acquisitions depending on the timing and size of the acquisition. Our future long-term capital requirements will depend on many factors including our level of sales, the impact of the economic environment on our sales growth, the timing and extent of spending to support development efforts, the expansion of the global sales and marketing activities, government regulation including trade sanctions, the timing and introductions of new products, the need to ensure access to adequate manufacturing capacity and the continuing market acceptance of our products.

The following table details our line-of-credit facilities as of March 31, 2019:

| Description | Total Facility | Interest Rate | Maturity | Security |
| --- | --- | --- | --- | --- |
| U.S. Revolving Line of Credit (1) | $50.0 million | LIBOR plus 0.80% to 1.20%, depending on our performance | April 2020 | Unsecured |
| Euro Credit Facility (Germany) (2) | Euro 50.0 million ($56.1 million) | Euribor plus 0.75% or EONIA 1.00% | July 2020 | Unsecured, guaranteed by parent company and German subsidiary |
| Other Euro Facility (3) | Euro 2.0 million ($2.2 million) | Euribor plus 0.89% to 1.10% | May 2019 | Common pool of assets of Italian subsidiary |

(1) This facility is available to certain foreign subsidiaries in their respective local currencies. At March 31, 2019, there were no amounts drawn on this line, however, there were $0.9 million of guarantees issued against the line which reduces total availability.

(2) This facility is also available to certain foreign subsidiaries in their respective local currencies. At March 31, 2019, there were no drawings on this facility, however, there were $1.6 million of guarantees issued against the line which reduces total availability.

(3) At March 31, 2019, there were no drawings. This facility renews annually.

Our largest committed credit lines are with Bank of America N.A. and Deutsche Bank AG in the amounts of $50.0 million and $56.1 million (or 50 million Euro as described above), respectively, and neither of them is syndicated.

We are required to meet certain financial covenants associated with our U.S. revolving line of credit and long-term debt facility. These covenants, tested quarterly, include a debt service coverage ratio and a funded debt to earnings before interest, taxes, depreciation and amortization ("EBITDA") ratio. The debt service coverage covenant requires that we maintain a trailing twelve month ratio of cash flow to debt service that is at least 1.5:1. Debt service is defined as required principal and interest payments during the period. Debt service in the calculation is decreased by our cash held in the U.S.A. in excess of $50 million up to a maximum of $250 million. Cash flow is defined as EBITDA less unfunded capital expenditures. The funded debt to EBITDA covenant requires that the sum of all indebtedness for borrowed money on a consolidated basis be less than three times our trailing twelve months EBITDA. We were in compliance with all such financial covenants as of and for the three months ended March 31, 2019.

The financial covenants in our loan documents may cause us to not make or to delay investments and actions that we might otherwise undertake because of limits on capital expenditures and amounts that we can borrow or lease. In the event that we do not comply with any one of these covenants, we would be in default under the loan agreement or loan agreements, which may result in acceleration of the debt, cross-defaults on other debt or a reduction in available liquidity, any of which could harm our results of operations and financial condition.

*Operating activities.* Net cash provided by operating activities decreased by $56.0 million to $43.7 million for the three months ended March 31, 2019 from $99.7 million for the three months ended March 31, 2018. Our largest working capital items are inventory and accounts receivable. Items such as accounts payable to third parties, prepaid expenses and other current assets and accrued expenses and other liabilities are not as significant as our working capital investment in accounts receivable and inventory because of the amount of value added within IPG due to our vertically integrated structure. Accruals and payables for personnel costs including bonuses and income and other taxes payable are largely dependent on the timing of payments for those items. The decreased cash flow from operating activities for the three months ended March 31, 2019 primarily resulted from:

- A decrease of $41.3 million in cash provided by net income after adding back non-cash charges to $105.4 million for the three months ended March 31, 2019 as compared to $146.7 million for the same period in 2018;
- An increase in cash used by income taxes. Cash used by income and other taxes payable was $57.8 million for the three months ended March 31, 2019 as compared to cash provided by income and other taxes payable of $5.3 million for the same period in 2018 due to timing of tax payments in Germany; partially offset by
- An increase in the cash provided by accounts receivable of $22.9 million for the three months ended March 31, 2019 as compared to $7.9 million for the same period in 2018; and
- A decrease in the cash used for inventory. Cash used for inventory was $19.7 million for the three months ended March 31, 2019 as compared to $49.7 million for the same period in 2018.

Given our vertical integration, rigorous and time-consuming testing procedures for both internally manufactured and externally purchased components and the lead time required to manufacture components used in our finished products, the rate at which we turn inventory has historically been comparatively low when compared to our cost of sales. Also, our historic growth rates required investment in inventories to support future sales and enable us to quote short delivery times to our customers, providing what we believe is a competitive advantage. Furthermore, if there was a disruption to the manufacturing capacity of any of our key technologies, our inventories of components should enable us to continue to build finished products for a period of time. We believe that we will continue to maintain a relatively high level of inventory compared to our cost of sales. As a result, we expect to have a significant amount of working capital invested in inventory. A reduction in our level of net sales or the rate of growth of our net sales from their current levels would mean that the rate at which we are able to convert our inventory into cash would decrease.

*Investing activities.* Net cash used in investing activities was $23.2 million for the three months ended March 31, 2019 as compared to cash used in investing activities of $39.4 million in 2018. The cash used in investing activities in 2019 related to $33.0 million of capital expenditures and $15.1 million for acquisition of business, partially offset by $24.8 million of net proceeds of short-term investments. The cash used in investing activities in 2018 related to $39.1 million of capital expenditures and $0.6 million of net purchases of short-term investments.

We expect to incur between $160 million and $180 million in 2019 in capital expenditures. Capital expenditures include investments in facilities and equipment to add capacity worldwide to support anticipated revenue growth. In 2019, we expect capital expenditures to increase as a percentage of revenue to support the growth of our business. The timing and extent of any capital expenditures in and between periods can have a significant effect on our cash flow. If we obtain financing for certain projects, our cash expenditures would be reduced in the year of expenditure. Many of the capital expenditure projects that we undertake have long lead times and are difficult to cancel or defer to a later period.

*Financing activities.* Net cash used in financing activities was $7.0 million for the three months ended March 31, 2019 as compared to net cash used of $17.9 million in 2018. The cash used in financing activities in 2019 was primarily related to $6.1 million for payments of taxes related to net share settlement of equity awards and $0.9 million of principal payments on our long-term borrowings. The cash used in financing activities in 2018 was primarily related to the purchase of treasury stock of $20.1 million and $0.9 million of principal payments on long-term borrowings, partially offset by proceeds of $3.1 million from the exercise of stock options.

### Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements contained in this Quarterly Report on Form 10-Q except for historical information are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. In addition, any statements that refer to projections of our future financial performance, trends in our businesses, or other characterizations of future events or circumstances are forward-looking statements.

The forward-looking statements included herein are based on current expectations of our management based on available information and involve a number of risks and uncertainties, all of which are difficult or impossible to accurately predict and many of which are beyond our control. As such, our actual results may differ significantly from those expressed in any forward-looking statements. Factors that may cause or contribute to such differences include, but are not limited to, those discussed in more detail in Item 1, "Business" and Item 1A, "Risk Factors" of Part I of our Annual Report on Form 10-K for the year ended December 31, 2018. Readers should carefully review these risks, as well as the additional risks described in other documents we file from time to time with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by us or any other person that such results will be achieved, and readers are cautioned not to rely on such forward-looking information. We undertake no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

### Recent Accounting Pronouncements

See Note 2 in the Notes to Consolidated Financial Statements for a full description of recent accounting pronouncements, including the respective dates of adoption or expected adoption and effects on our consolidated financial statements contained in Item 1 of this Quarterly Report.

## Market risk

As filed, 5,345 characters.

We are exposed to market risk in the ordinary course of business, which consists primarily of interest rate risk associated with our cash and cash equivalents and our debt and foreign exchange rate risk.

*Interest rate risk*. Certain interest rates are variable and fluctuate with current market conditions. Our investments have limited exposure to market risk. We maintain a portfolio of cash, cash equivalents and short-term investments, consisting primarily of bank deposits, money market funds, certificates of deposit, commercial paper, corporate bonds and government and agency securities. None of these investments have a maturity date in excess of one year. Because of the short-term nature of these instruments, a sudden change in market interest rates would not be expected to have a material impact on our financial condition or results of operations. We also have long-term investments in auction rate securities with maturities greater than 5 years. Given the modest amount of our long-term investments of $0.9 million and the fact that we expect to hold these investments to maturity, we do not believe that a 10% change in market interest rates would have a material impact on our financial position or results of operations.

We are also exposed to market risk as a result of increases or decreases in the amount of interest expense we must pay on our bank debt and borrowings on our bank credit facilities. Our interest obligations on our long-term debt are fixed either by the underlying agreement or by means of an interest rate swap agreement. Although our U.S. revolving line of credit and our Euro credit facility have variable rates, we do not believe that a 10% change in market interest rates would have a material impact on our financial position or results of operations.

*Exchange rates.* Due to our international operations, a significant portion of our net sales, cost of sales and operating expenses are denominated in currencies other than the U.S. Dollar, principally the Euro, the Russian Ruble, the Chinese Yuan and the Japanese Yen. As a result, our international operations give rise to transactional market risk associated with exchange rate movements of the U.S. Dollar, the Euro, the Russian Ruble, the Chinese Yuan and the Japanese Yen. The loss on foreign exchange transactions totaled $1.6 million for the three months ended March 31, 2019 compared to a gain of $5.3 million for the three months ended March 31, 2018. Management attempts to minimize these exposures by partially or fully off-setting foreign currency denominated assets and liabilities at our subsidiaries that operate in different functional currencies. The effectiveness of this strategy can be limited by the volume of underlying transactions at various subsidiaries and by our ability to accelerate or delay inter-company cash settlements. As a result, we are unable to create a perfect offset of the foreign currency denominated assets and liabilities. At March 31, 2019, our material foreign currency exposure is net U.S. Dollar denominated assets at subsidiaries where the Euro or the Russian Ruble is the functional currency and U.S. Dollar denominated liabilities where the Chinese Yuan is the functional currency. The U.S. Dollar denominated assets are comprised of cash, third party receivables and inter-company receivables. The U.S. Dollar denominated liabilities are comprised of inter-company payables. A 5% change in the relative exchange rate of the U.S. Dollar to the Euro as of March 31, 2019 applied to the net U.S. Dollar asset balances, would result in a foreign exchange gain of $3.9 million if the U.S. Dollar appreciated and a $3.9 million foreign exchange loss if the U.S. Dollar depreciated. A 5% change in the relative exchange rate of the U.S. Dollar to the Chinese Yuan as of March 31, 2019 applied to the net U.S. Dollar liabilities balances, would result in a foreign exchange loss of $5.9 million if the U.S. Dollar appreciated and a $5.9 million foreign exchange gain if the U.S. Dollar depreciated.

In addition we are exposed to foreign currency translation risk for those subsidiaries whose functional currency is not the U.S. Dollar as changes in the value of their functional currency relative to the U.S. Dollar can adversely affect the translated amounts of our revenue, expenses, net income, assets and liabilities. This can, in turn, affect the reported value and relative growth of sales and net income from one period to the next. In addition changes in the translated value of assets and liabilities due to changes in functional currency exchange rates relative to the U.S. Dollar result in foreign currency translation adjustments that are a component of other comprehensive income or loss.

Foreign currency derivative instruments can also be used to hedge exposures and reduce the risks of certain foreign currency transactions; however, these instruments provide only limited protection and can carry significant cost. We have no foreign currency derivative instruments as of March 31, 2019. We will continue to analyze our exposure to currency exchange rate fluctuations and may engage in financial hedging techniques in the future to attempt to minimize the effect of these potential fluctuations. Exchange rate fluctuations may adversely affect our financial results in the future.

## Controls and procedures

As filed, 1,030 characters.

### Evaluation of Disclosure Controls and Procedures

Under the supervision of our chief executive officer and our chief financial officer, our management has evaluated the effectiveness of the design and operation of our "disclosure controls and procedures" (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this Quarterly Report on Form 10-Q (the "Evaluation Date"). Based upon that evaluation, our chief executive officer and our chief financial officer have concluded that, as of the Evaluation Date, our disclosure controls and procedures are effective.

### Changes in Internal Controls

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act) that occurred during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 637 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2018, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Filed May 8, 2019.
Source: SEC EDGAR, the filing index for accession 0001111928-19-000079. Last ingested by Listed: Nov 4, 2026, 17:26 ET. No prices; not investment advice.
